HOME >> BIOLOGY >> NEWS
Top biomedical researchers form Editorial Directorate for open-access publishing venture

Some of the world's leading biological and medical scientists have joined the Editorial Directorate of BioMed Central, a new publishing house that will give free on-line access to biomedical research. BioMed Central will allow researchers around the world to access peer-reviewed research articles free-of-charge, and without the traditional barriers to access imposed by conventional publishers. The BioMed Central Directorate includes:

PROFESSOR ELIZABETH H. BLACKBURN
Professor of Biochemistry and Biophysics and Professor of Microbiology and Immunology at the University of California, San Francisco (USA)

DR STEVEN E. HYMAN
Director of the National Institute of Mental Health (USA)

PROFESSOR MARC W. KIRSCHNER
Head of the Department of Cell Biology at Harvard Medical School. (USA)

PROFESSOR PHILIPPE KOURILSKY
Professor of the Collège de France and Director General of the Pasteur Institute (France)

PROFESSOR JOSEPH BOYD MARTIN
Dean of the Faculty of Medicine at Harvard Medical School (USA)

DR DAVID G. NATHAN
President of the Dana-Farber Cancer Institute (USA)

DR PAUL NURSE
Director-General of the Imperial Cancer Research Fund (UK).

DR HAROLD E. VARMUS
President of the Memorial Sloan-Kettering Cancer Center (USA)

PROFESSOR SIR DAVID WEATHERALL
Regius Professor of Medicine at the University of Oxford (UK)

PROFESSOR MITSUHIRO YANAGIDA
Professor of Kyoto University, Graduate School of Biostudies (Japan)

"BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime", says Dr Paul Nurse.

"BioMed Central and other on-line initiatives will serve to make science more democratic, and more efficient, and in so doing will speed scientific progress," says Dr Steven Hyman. "In the long run, I think that journals that are not freely available in electronic formats will be read less and less".

"BioMed Central promises to d
'"/>

Contact: Andrew McLaughlin
andrew@biomedcentral.com
44-20-7323-0323
BioMed Central
21-May-2000


Page: 1 2 3

Related biology news :

1. Illustrated guidebook published for Chinese biomedical scientists and students
2. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
3. Ottawas leadership in biomedical and health research has paid off
4. New world record magnet for chemical and biomedical research
5. Telescience recognized for facilitating biomedical research on a global network
6. Digital Biology Week: Building a national infrastructure for biomedical computing
7. New grants enable biomedical research centers to share science with their communities
8. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
9. UW-Madison scientists return to rat as biomedical research tool
10. Stanford biomedical ethicist speaks on role of race in scientific research
11. University of New Hampshire launches biomedical research network with $5.6 million grant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium ... announced the appointment of new CEO James ... executive with decades of experience, has served in ... Cisco, where he specialized in expanding a pipeline ... technology portfolios. He most recently served as managing ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017  Protagonist Therapeutics, Inc. ... it has initiated a global Phase 2b induction ... peptide that targets alpha4beta7 integrin. The aim of ... to evaluate the safety/tolerability and efficacy of PTG-100 ... moderate to severe active disease. ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today announced ... allow more customers to receive their primers in a ... compromise in quality found with other providers. Express oligos ... States at no additional fee. ... genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, and ...
(Date:1/13/2017)... ... January 13, 2017 , ... Two Kalamazoo entrepreneurs have ... fulvic acid that farms, greenhouses and hydroponics operations use to increase yields and ... fastest growing segments of customers using this high grade fulvic acid extracted from ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... of performing routine electrochemical biosensing has increased dramatically. Primarily driven by the ... and quantification of various analytes in complex samples. , Screen-printed ...
Breaking Biology Technology:
Cached News: